2009
DOI: 10.1111/j.1538-7836.2009.03407.x
|View full text |Cite
|
Sign up to set email alerts
|

Defining human endothelial progenitor cells

Abstract: Summary.  There is no specific marker to identify an endothelial progenitor cell (EPC) and this deficiency is restricting the ability of an entire field of research in defining these cells. We will review current methods to define EPC in the human system and suggest approaches to define better the cell populations involved in neoangiogenesis. PubMed was used to identify articles via the search term ‘endothelial progenitor cell’ and those articles focused on defining the term were evaluated. The only human cell… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
138
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 158 publications
(142 citation statements)
references
References 39 publications
3
138
0
Order By: Relevance
“…However, conflicting results have been reported in the field, and the identification and characterization of EPCs in vascular biology is still a subject of much discussion. Yoder (2009) has concluded that EPCs could be defined by three general approaches in the human system: method of culture and the morphological criteria; monoclonal antibodies and fluorescence activated cell sorting (FACS) analysis to enumerate specific cell populations; colony forming assay in vitro, though all of these approaches have defects. In most reports, combination of different surface markers was embraced for the identification of EPCs.…”
Section: Discussionmentioning
confidence: 99%
“…However, conflicting results have been reported in the field, and the identification and characterization of EPCs in vascular biology is still a subject of much discussion. Yoder (2009) has concluded that EPCs could be defined by three general approaches in the human system: method of culture and the morphological criteria; monoclonal antibodies and fluorescence activated cell sorting (FACS) analysis to enumerate specific cell populations; colony forming assay in vitro, though all of these approaches have defects. In most reports, combination of different surface markers was embraced for the identification of EPCs.…”
Section: Discussionmentioning
confidence: 99%
“…BOECs belong to the family of endothelial progenitor cells (EPCs), which harbors a heterogeneous selection of different cell types, participating in and modulating neovascularization. Distinct EPC subtypes are defined using different culture techniques and/or combinations of cell surface markers 1, 2, 3. BOECs, also referred to as circulating endothelial colony‐forming cells (ECFCs) or late outgrowth EPCs, are the only cell type featuring the characteristics of a “true” EPC, given that these cells are self‐renewing, clonogenic, and able to form capillary‐like structures and integrate into functional blood vessels in vitro and in vivo, respectively 4…”
Section: Introductionmentioning
confidence: 99%
“…This defective endothelial repair could be normalized by transfusion of progenitor cells from insulin-sensitive animals, but not from insulin-resistant animals (Kahn et al, 2011). However, it is thought that EPCs biological modifications are mostly affected by IR in an indirect fashion, through the increase in ROS and also by the activation of pro-inflammatory cytokines (Cubbon et al, 2007;2009;Houstis et al, 2006). In fact, IR states are closely linked to the increased production of ROS, which is a characteristic feature of IR and thought to play a causal role in its development (Houstis et al, 2006).…”
Section: Insulin Resistance (Ir)mentioning
confidence: 99%
“…The characterization of these different subpopulations of EPCs is due to the different methodology used for cell isolation. To date, there are three main techniques that have been used to select, identify and characterize EPCs (Hirschi et al, 2008;Yoder, 2009). The cell types isolated using the different protocols are not phenotypically similar and as such, their www.intechopen.com potential to influence neovascularization and/or vascular repair may vary.…”
Section: Epcs Phenotypic and Functional Propertiesmentioning
confidence: 99%